Literature DB >> 9743898

Uterine luminal epithelial alkaline phosphatase activity and pinopod development in relation to endometrial sensitivity in the rat.

F W Bansode1, S C Chauhan, A Makker, M M Singh.   

Abstract

The period of maximal endometrial sensitivity in the rat was characterized by high alkaline phosphatase activity in uterine luminal and glandular epithelium and endometrial stroma. The activity in endometrial stroma increased following decidualization. Pinopod development on the endometrial surface was first observed during the presensitivity period. Their number increased, apparently more so on the antimesometrial rather than the mesometrial segment of the uterus, on the day of maximal sensitivity. Inhibition in endometrial sensitivity by single anti-implantation (1.25 mg/kg, po) dose of centchroman on day 1 post-coitum (p.c.), although it did not affect alkaline phosphatase activity on days 2 and 3 p.c., caused complete inhibition in its activity in uterine luminal and glandular epithelium and pinopod development on days 4 and 5-coinciding, respectively, with time of entry of preimplantation embryos into the uterus and period of maximal endometrial sensitivity in this species. Significant decrease in enzyme activity was also evident in the entire endometrial stroma and myometrium, except blood capillaries, on these days. In comparison, prevention of entry of native embryos into the uterus by placing a ligature at the utero-tubal junction had no effect on pinopod development, but caused marked decrease in enzyme activity in luminal and glandular epithelium only during the immediate postimplantation period. The uterine lumen on the day of maximal sensitivity in centchroman-treated rats appeared highly distended and was lined with tall columnar epithelium, in comparison to low cuboidal epithelium in controls. The findings demonstrate: (a) a correlation between uterine luminal epithelial alkaline phosphatase activity and endometrial sensitivity; (b) complete inhibition in enzyme activity in luminal and glandular epithelium following centchroman treatment might be related to altered permeability characteristics of epithelial cells, which together with the absence of pinopods and highly distended uterine lumen on the day of maximal sensitivity, suggest inhibition of endocytosis/pinocytosis of luminal fluid, luminal closure, apposition of blastocyst trophoblast to luminal epithelium, and secretory activity of glandular epithelium; (c) pinopod development on the endometrial surface was independent of presence of viable blastocysts in utero; and (d) complete absence of pinopods suggests lack of endometrial sensitivity, but their presence might not necessarily indicate a sensitized endometrium in the rat.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743898     DOI: 10.1016/s0010-7824(98)00055-9

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

1.  Nanoparticle formulation of ormeloxifene for pancreatic cancer.

Authors:  Sheema Khan; Neeraj Chauhan; Murali M Yallapu; Mara C Ebeling; Swathi Balakrishna; Robert T Ellis; Paul A Thompson; Pavan Balabathula; Stephen W Behrman; Nadeem Zafar; Man M Singh; Fathi T Halaweish; Meena Jaggi; Subhash C Chauhan
Journal:  Biomaterials       Date:  2015-03-26       Impact factor: 12.479

2.  Placentation in the eastern water skink (Eulamprus quoyii): a placentome-like structure in a lecithotrophic lizard.

Authors:  Bridget F Murphy; Scott L Parker; Christopher R Murphy; Michael B Thompson
Journal:  J Anat       Date:  2011-03-24       Impact factor: 2.610

3.  Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium.

Authors:  Elisabet Aliagas; August Vidal; Benjamín Torrejón-Escribano; Maria del Rosario Taco; Jordi Ponce; Inmaculada Gómez de Aranda; Jean Sévigny; Enric Condom; Mireia Martín-Satué
Journal:  Purinergic Signal       Date:  2012-12-06       Impact factor: 3.765

4.  Ormeloxifene efficiently inhibits ovarian cancer growth.

Authors:  Diane M Maher; Sheema Khan; Jordan L Nordquist; Mara C Ebeling; Nichole A Bauer; Lucas Kopel; Man Mohan Singh; Fathi Halaweish; Maria C Bell; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Lett       Date:  2014-10-13       Impact factor: 8.679

5.  Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells.

Authors:  Neeraj Chauhan; Amber Kruse; Hilary Newby; Meena Jaggi; Murali M Yallapu; Subhash C Chauhan
Journal:  ACS Omega       Date:  2020-01-09

6.  Editor's Highlight: Development of an In vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment.

Authors:  Michelle M Miller; Rebecca A Alyea; Caroline LeSommer; Daniel L Doheny; Sean M Rowley; Kristin M Childs; Pergentino Balbuena; Susan M Ross; Jian Dong; Bin Sun; Melvin A Andersen; Rebecca A Clewell
Journal:  Toxicol Sci       Date:  2016-08-07       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.